News

ProKidney Set to Present Novel CKD Research at Kidney Week

ProKidney Set to Present Novel CKD Research at Kidney Week

Exciting News from ProKidney Corp.

ProKidney Corp. (NASDAQ: PROK), known for its innovative solutions in chronic kidney disease (CKD), is thrilled to announce that it will present two significant abstracts at the American Society of Nephrology's (ASN) Kidney Week 2025. This annual conference, bringing together experts and researchers in nephrology, offers a platform for the latest advancements in kidney health. ProKidney's participation underlines its commitment to addressing critical aspects of CKD through cellular therapeutics.

Highlights of the Presentation

Among the presentations will be a late-breaking poster detailing the Phase 2 REGEN-007 study results. This study investigates the potential of ProKidney's lead product, rilparencel, in treating diabetes-related kidney damage. The REGEN-007 study shows promise in energizing the conversation around effective treatments for CKD and diabetes, which often go hand-in-hand. ProKidney’s emphasis on cellular therapy is positioned to make a significant impact on patient outcomes.

About the Late-Breaking Presentation

Renal Autologous Cell Therapy in Diabetes and CKD (Phase 2 REGEN-007 Study Results)
Session Title: Late-Breaking Science Posters [LB-PO]
Session Date, Time: November 6, 2025, from 10:00 AM to 12:00 PM CST
Poster Board #: TH-PO1203

Exploring Further Research Topics

In addition to the late-breaking poster, ProKidney will also present another impactful poster titled, Cell-Specific Inflammatory Profile Characterization of the Cell Therapy Candidate Rilparencel. This presentation will delve into how understanding inflammatory profiles can enhance the development of individualized therapies for CKD patients, further showcasing ProKidney's commitment to innovative research.

Other Poster Presentation Details

Session Title: Development, Stem Cells, and Regenerative Medicine [PO0600]
Session Date, Time: November 6, 2025, from 10:00 AM to 12:00 PM CST
Poster Board #: TH-PO0575

Company Commitment to Knowledge Sharing

Post-event, ProKidney aims to promote transparency and knowledge sharing by making the poster presentations available on its official website. This effort illustrates ProKidney’s dedication not only to innovation in product development but also to disseminating valuable research findings within the medical community.

Availability of Poster Presentations

After the conference, attendees and interested parties can find copies of the presentations on the company's website at https://prokidney.com/our-technology/publications/.

ProKidney's Mission in CKD

Founded in 2015, ProKidney is a frontrunner in CKD treatment through advanced cellular therapies. The company’s flagship product, rilparencel, is designed to provide innovative treatment options for patients facing advanced CKD and type 2 diabetes. ProKidney's research continues to set new standards in regenerative medicine, highlighting the potential for improved patient care.

Stay Updated with ProKidney

To keep pace with advancements in CKD therapies, stakeholders are encouraged to follow ProKidney's developments. The company is active in exploring new treatments aimed at preserving kidney function, which is of critical importance given the increasing prevalence of CKD worldwide.

Contact Information

ProKidney Contact
Ethan Holdaway
Email: Ethan.Holdaway@prokidney.com

Media Contact

Audra Friis
Email: audrafriis@sambrown.com

Investor Relations Contact

Daniel Ferry
Email: Daniel@lifesciadvisors.com

Frequently Asked Questions

What is the main focus of ProKidney Corp.?

ProKidney Corp. focuses on innovative cellular therapeutics for treating chronic kidney disease (CKD).

When will ProKidney present its research?

The presentations at the ASN Kidney Week are scheduled for November 6, 2025.

What are the key topics being presented?

Key topics include the Phase 2 REGEN-007 study results and the inflammatory profile of the therapy candidate rilparencel.

Where can I find more information about the presentations?

Copies of the presentations will be available on ProKidney's website after the event.

How can I contact ProKidney for inquiries?

Contact Ethan Holdaway at Ethan.Holdaway@prokidney.com for more information.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

WellNet Embraces Voice AI for Provider Calls

Updated Category News Views 25

Ever met a TPA grappling over their provider call costs like a crusty sailor with a rusted anchor? Welcome to WellNet Healthcare, folks. They've tapped EHVAhealth's conversational voice AI to take a solid swing at automating those burdensome provider calls. They're no stranger to the chaos of managing member eligibility and benefits verification, and this move might just...

Continue Reading
US Foods Faces Major Strike Threat Over Driver Contracts

Updated Category News Views 158

Teamsters Prep for Possible Strike Against US Foods You can almost hear the union drums beating as 260 drivers from Teamsters Local 282 in New York gear up for what could be a major confrontation with US Foods. The message is loud and clear: pay us what we're worth, or watch your delivery chain grind to a halt. With unanimous approval to strike, this isn't just a...

Continue Reading
Crocs™ Gains C2C Circularity Gold for Classic Clogs

Updated Category News Views 43

Turning Plastic into Gold Well, folks, Crocs isn't just about comfort anymore. They're wrapping their iconic Classic Clog in a shiny new accolade: Cradle to Cradle Certified® Circularity Gold Version 5.0. Imagine that—an award for making something meant to last, designed to be repurposed. They're not just slapping new paint on the same old clogs either. This...

Continue Reading
Tigo Energy Faces Legal Heat Over Fraud Allegations

Updated Category News Views 100

Tigo Energy's Legal Battle Heats Up If you haven't been paying attention, it’s time to get your eyes on Tigo Energy (NASDAQ: TYGO). The company is now in the hot seat with a securities fraud lawsuit that's got investors on edge. This isn’t just a minor squabble; we're talking about allegations that could shake the ground beneath its share price. The Claims and...

Continue Reading
Hospitals Face $392M Squeeze Under Medicare's CJR-X

Updated Category News Views 99

Medicare's CJR-X Challenges Hospitals 2028 is setting up to be a year hospitals across the U.S. remember, not with a smile, but likely with clenched teeth. Medicare's CJR-X model is ready to put about 2,217 hospitals in a financial vise over hip, knee, and ankle replacements. Going into effect on January 1, 2028, this mandate turns health networks' profit dreams into a...

Continue Reading
Annual Home Insurance Check: Paul Bernieri's Top Tips

Updated Category News Views 9

Don't Sleep on Your Annual Insurance Review Ever feel like insurance policy reviews are one of those boring chores? Well, Paul Bernieri would probably say they're anything but. In a recent HelloNation article, our favorite insurance expert, Paul Bernieri from Garden City, NY, dissects the crucial areas homeowners on Long Island need to examine each year. It's basically a...

Continue Reading
Zuellig Pharma Expands Clinical Capabilities in China

Updated Category News Views 135

Zuellig Pharma's Strategic Leap in Hangzhou You know, in the ever-evolving world of biotech and pharmaceuticals, setting up shop in the right locale can mean the difference between breakthroughs and breakdowns. So Zuellig Pharma—a major player, but not exactly a household ticker—made a smart move acquiring a clinical facility in Hangzhou. This is no minor shuffle;...

Continue Reading
Zayne Burgess Accelerates Towards Formula 1 with K1 Speed

Updated Category News Views 78

A Young Racer's Roaring Start Every once in a while, a kid shows up on the scene who just makes you sit up and pay attention. Enter Zayne Burgess, a mere 10-year-old with the skill set of a seasoned pro. If you care about the future of racing, you better start watching this young'un, because he's chasing a Formula 1 dream and has K1 Speed putting their chips on him....

Continue Reading
Markets Split on Election Day: Dow Dips, Nasdaq Soars

Updated Category News Views 92

Election Day rolled in like a wild card, with markets doing their dance that makes seasoned traders either groan or grin. This time, Tuesday saw the Dow slipping while the Nasdaq climbed higher, reflecting a split personality kind of session. Ain't it funny how one day can hold such different tales depending on which index gets your focus? Indices' Dance: Dow Down, Nasdaq...

Continue Reading
Crude Insight: Refining Margins Expand, LNG Orders Rise

Updated Category News Views 27

Refining Margins Stretch While LNG Orders Surge Well, folks, oil markets have sure been a rollercoaster lately. WTI futures danced all over the place, closing near $96 a barrel after brushing against both $93 and $99 earlier this week. Brent wasn't left out of the tango, setting at $103.60. Everyone's holding their breath each time these numbers come through. Energy...

Continue Reading

Top 5 Most Recently Viewed Articles

Enlight Launches Tapolca Solar Facility, Boosting Capacity in Hungary

Updated Category News Views 218

Enlight Announces the Start of Commercial Operations at the Tapolca Solar Project The Tapolca solar project features an impressive capacity of 60 MW, with a total investment of $48 million dedicated to its construction. This project marks Enlight's fifth initiative in Hungary, boosting the Company's total operational generation capacity in the country to 144 MW. TEL AVIV,...

Continue Reading
Innovative Green Ammonia Technology Receives Funding Boost

Updated Category News Views 186

NitroFix and 1s1 Energy Secure Grant for Green Ammonia Project NitroFix, an innovative climate technology company, and 1s1 Energy, a pioneer in advanced electrochemical systems, are embarking on an exciting joint venture to develop a cutting-edge green ammonia generator. This collaborative effort has been elevated with the awarding of a prestigious grant from the...

Continue Reading
ETC Reports Impressive Q2 2026 Financial Growth Results

Updated Category News Views 164

ETC's Financial Performance for Q2 2026 Environmental Tectonics Corporation (OTC: ETCC) has recently shared its financial results for the second quarter of fiscal year 2026. The company has showcased impressive growth in sales, indicating a strong trajectory for its business. During this quarter, the company reported net income of $1.5 million, translating to $0.08 in...

Continue Reading
Galecto's Strategic Advances in Oncology and Treatment Pipeline

Updated Category News Views 316

Galecto’s Focus on Oncology and Financial Overview Galecto, Inc. (NASDAQ: GLTO), a dynamic player in the biotechnology sector, specializes in innovation for cancer and fibrosis treatments. The company recently released its financial results for the year ending December 31, 2024, illustrating progress and emphasizing its strategic focus. A notable highlight from the year...

Continue Reading
Waystar's Leadership to Share Insights at Upcoming Events

Updated Category News Views 142

Waystar's Leadership to Present at Investor Conferences Waystar, a prominent provider of healthcare payment software, has solidified its role in the healthcare sector by focusing on innovative solutions that enhance efficiency in payment processing. The company, known for its mission-critical software, is gearing up for two major investor conferences where its Chief...

Continue Reading